BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park SH, Phuc NM, Lee J, Wu Z, Kim J, Kim H, Kim ND, Lee T, Song KS, Liu KH. Identification of acetylshikonin as the novel CYP2J2 inhibitor with anti-cancer activity in HepG2 cells. Phytomedicine 2017;24:134-40. [PMID: 28160853 DOI: 10.1016/j.phymed.2016.12.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Hong M, Li J, Li S, M Almutairi M. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation. Cells 2019;8:E1466. [PMID: 31752383 DOI: 10.3390/cells8111466] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ikemura N, Yamaori S, Kobayashi C, Kamijo S, Murayama N, Yamazaki H, Ohmori S. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine. Chemico-Biological Interactions 2019;306:1-9. [DOI: 10.1016/j.cbi.2019.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
3 Sisignano M, Steinhilber D, Parnham MJ, Geisslinger G. Exploring CYP2J2: lipid mediators, inhibitors and therapeutic implications. Drug Discovery Today 2020;25:1744-53. [DOI: 10.1016/j.drudis.2020.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lu J, Liu D, Zhou X, Chen A, Jiang Z, Ye X, Liu M, Wang X. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme. Phytomedicine 2018;39:137-45. [PMID: 29433675 DOI: 10.1016/j.phymed.2017.12.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shon JC, Phuc NM, Kim WC, Heo JK, Wu Z, Lee H, Liu KH. Acetylshikonin is a novel non-selective cytochrome P450 inhibitor. Biopharm Drug Dispos 2017;38:553-6. [PMID: 28866862 DOI: 10.1002/bdd.2101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Roh JS, Lee H, Lim J, Kim J, Yang H, Yoon Y, Shin SS, Yoon M. Effect of Gangjihwan on hepatic steatosis and inflammation in high fat diet-fed mice. Journal of Ethnopharmacology 2017;206:315-26. [DOI: 10.1016/j.jep.2017.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Vukic MD, Vukovic NL, Popovic SL, Todorovic DV, Djurdjevic PM, Matic SD, Mitrovic MM, Popovic AM, Kacaniova MM, Baskic DD. Effect of β-cyclodextrin encapsulation on cytotoxic activity of acetylshikonin against HCT-116 and MDA-MB-231 cancer cell lines. Saudi Pharm J 2020;28:136-46. [PMID: 31920439 DOI: 10.1016/j.jsps.2019.11.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wang J, Iannarelli R, Pucciarelli S, Laudadio E, Galeazzi R, Giangrossi M, Falconi M, Cui L, Navia AM, Buccioni M, Marucci G, Tomassoni D, Serini L, Sut S, Maggi F, Dall'Acqua S, Marchini C, Amici A. Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice. Pharmacol Res 2020;161:105123. [PMID: 32822867 DOI: 10.1016/j.phrs.2020.105123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lee HK, Lim HM, Park SH, Nam MJ. Knockout of Hepatocyte Growth Factor by CRISPR/Cas9 System Induces Apoptosis in Hepatocellular Carcinoma Cells. J Pers Med 2021;11:983. [PMID: 34683124 DOI: 10.3390/jpm11100983] [Reference Citation Analysis]
10 Zhang Q, Cai D, Wang L, Yang X, Fan S, Zhang K. Rapid and sensitive determination of shikonin and its derivatives in the roots of Arnebia euchroma (Royle) Johnst using matrix solid-phase dispersion extraction and ultrahigh-performance liquid chromatography with photodiode array detector. Journal of Liquid Chromatography & Related Technologies 2018;41:489-97. [DOI: 10.1080/10826076.2018.1467836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Feng Y, Clayton J, Yake W, Li J, Wang W, Winne L, Hong M. Resveratrol Derivative, Trans-3, 5, 4'-Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS-Induced Caspases Activation. Oxid Med Cell Longev 2021;2021:8840692. [PMID: 33833855 DOI: 10.1155/2021/8840692] [Reference Citation Analysis]
12 Lim HM, Lee J, Yu SH, Nam MJ, Cha HS, Park K, Yang Y, Jang KY, Park S, Chen L. Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/9139338] [Reference Citation Analysis]
13 Zhao R, Choi BY, Wei L, Fredimoses M, Yin F, Fu X, Chen H, Liu K, Kundu JK, Dong Z, Lee MH. Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase. Br J Pharmacol 2020;177:2303-19. [PMID: 31985814 DOI: 10.1111/bph.14981] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Park SH, Lee J, Shon JC, Phuc NM, Jee JG, Liu KH. The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation. Phytomedicine 2018;42:199-206. [PMID: 29655687 DOI: 10.1016/j.phymed.2018.03.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
15 Ersan RH, Alagoz MA, Dogen A, Duran N, Burmaoglu S, Algul O. Bisbenzoxazole Derivatives: Design, Synthesis, in Vitro Antimicrobial, Antiproliferative Activity, and Molecular Docking Studies. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2020.1852589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liu Y, Sun M, Yao H, Liu Y, Gao R. Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017. Evid Based Complement Alternat Med 2017;2017:8943059. [PMID: 29234439 DOI: 10.1155/2017/8943059] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
17 Lim HM, Lee J, Nam MJ, Park SH. Acetylshikonin Induces Apoptosis in Human Colorectal Cancer HCT-15 and LoVo Cells via Nuclear Translocation of FOXO3 and ROS Level Elevation. Oxid Med Cell Longev 2021;2021:6647107. [PMID: 33953834 DOI: 10.1155/2021/6647107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Cui J, Guo R, Wang Y, Song Y, Song X, Li H, Song X, Li J. Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway. Bioengineered 2022;13:4428-40. [PMID: 35139768 DOI: 10.1080/21655979.2022.2034584] [Reference Citation Analysis]
19 Zhang Z, Bai J, Zeng Y, Cai M, Yao Y, Wu H, You L, Dong X, Ni J. Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review. Pharm Biol 2020;58:950-8. [PMID: 32956595 DOI: 10.1080/13880209.2020.1818793] [Reference Citation Analysis]
20 Lee CM, Lee J, Jang SN, Shon JC, Wu Z, Park K, Liu KH, Park SH. 6,8-Diprenylorobol Induces Apoptosis in Human Hepatocellular Carcinoma Cells via Activation of FOXO3 and Inhibition of CYP2J2. Oxid Med Cell Longev 2020;2020:8887251. [PMID: 33312341 DOI: 10.1155/2020/8887251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Das A, Weigle AT, Arnold WR, Kim JS, Carnevale LN, Huff HC. CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design. Pharmacol Ther 2020;215:107601. [PMID: 32534953 DOI: 10.1016/j.pharmthera.2020.107601] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]